Table 3.
Summary of the radiopharmacy production units that reported producing 68Ga-labelled radiotracers or radiopharmaceuticals for molecular radiotherapy and the manufacturer licences they hold
| RPU | [68Ga]Ga-SSR | [68Ga]Ga-PSMA | MRT | MHRA licence |
|---|---|---|---|---|
| Radiopharmacy Unit, Barts Health NHS Trust | [68Ga]Ga-DOTA-TATE | [68Ga]Ga-PSMA-11 | – | MS and MIA(IMP) |
| NETSPOT kit | ANMI kit | |||
| Radiopharmacy Department, Queen Elizabeth Hospital, Birmingham | [68Ga]Ga-DOTA-TOC | – | – | MS |
| SOMAkit TOC kit | ||||
| Radiopharmacy, Nuclear Medicine, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust | [68Ga]Ga-DOTA-TATE | [68Ga]Ga-PSMA-11 | – | MS |
| NETSPOT kit | ANMI kit | |||
| Guy’s Radiopharmacy, Guy’s & St Thomas’ Foundation NHS Trust | [68Ga]-HA-DOTA-TATE | [68Ga]Ga-PSMA-11 | – | MS and MIA(IMP) |
| Automated synthesis unit | ANMI kit | |||
| [68Ga]Ga-DOTA-TATE | [68Ga]Ga-THP-PSMA | |||
| NETSPOT kit | GalliProst kit | |||
| [68Ga]Ga-DOTA-TOC | ||||
| SOMAkit TOC kit | ||||
| Radiopharmacy Unit, The Christie NHS Foundation Trust | [68Ga]Ga-DOTA-TOC | |||
| SOMAkit TOC | ||||
| (previously [68Ga]Ga-DOTA-NOC using automated synthesis unit) | – | – | MS | |
| Radiopharmacy, Nuclear Medicine, Royal Free London NHS Foundation Trust | [68Ga]Ga-DOTA-TATE | [68Ga]Ga-PSMA-11 | [90Y]Y-anti-CD66 | MS and MIA(IMP) |
| Automated synthesis unit | ANMI kit | |||
| [68Ga]Ga-DOTA-TATE | ||||
| NETSPOT kit | ||||
| Radiopharmacy Department, The Royal Marsden NHS Foundation Trust | [68Ga]Ga-DOTA-TATE | [68Ga]Ga-PSMA-11 | [177Lu]Lu-PSMA | MS |
| NETSPOT kit | ANMI kit | [90Y]Y-DOTA-TATE | ||
| [68Ga]Ga-DOTA-TOC | ||||
| SOMAkit TOC kit | ||||
| Radiopharmacy Department, University Hospitals Southampton NHS Foundation Trust | – | – | [177Lu]Lu-PSMA (antibody) | MS and MIA(IMP) |
| [227Th]Th-PSMA (antibody) | ||||
| [227Th]Th-mesothelium | ||||
| [90Y]Y-anti-CD66 |